The TRIUMPH-1 (obesity without T2D), TRIUMPH-2 (obesity with T2D) and TRIUMPH-3 (obesity with established cardiovascular disease) readouts are expected through 2026 per Lilly guidance 4
Were here to assist with expert, personalized data
Temporary side effects, especially when first starting or increasing your dose, can include mild nausea, vomiting, or stomach discomfort
Medication decisions made by clinicians differ from expectations formed during product selection
You can find previous posts in the Employer Coverage archive Please subscribe, like share this newsletter with friends and colleagues
Resistance Training: The Essential Partner While EAAs can stimulate muscle protein synthesis on their own, the magic happens when combined with resistance training